Balyasny Asset Management’s National Healthcare NHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-15,555
Closed -$1.66M 3290
2025
Q2
$1.66M Buy
+15,555
New +$1.55M ﹤0.01% 1830
2018
Q3
Sell
-4,038
Closed -$284K 1928
2018
Q2
$284K Sell
4,038
-2,200
-35% -$144K ﹤0.01% 1539
2018
Q1
$372K Sell
6,238
-6,600
-51% -$405K ﹤0.01% 1544
2017
Q4
$782K Sell
12,838
-2,600
-17% -$166K ﹤0.01% 1410
2017
Q3
$966K Buy
+15,438
New +$995K ﹤0.01% 1170

Other funds holding NHC

Balyasny Asset Management's NHC Position: Q3 2025 in Review

Balyasny Asset Management sold out of National Healthcare (NHC) in Q3 2025, closing a stake of 15,555 shares — an estimated $1.66M sold.

Balyasny Asset Management first reported a position in NHC in Q3 2017 and held it in 5 quarters. The position peaked at $1.66M in Q2 2025. 207 funds tracked by Wall St. Rank hold NHC as of Q3 2025.

  • Balyasny Asset Management reported no remaining National Healthcare position as of Q3 2025 after selling out during the quarter.
  • Balyasny Asset Management sold 15,555 National Healthcare shares in Q3 2025, an estimated $1.66M.
  • Balyasny Asset Management first reported a position in National Healthcare in Q3 2017 and held it in 5 quarters.
  • Balyasny Asset Management's National Healthcare position peaked at $1.66M in Q2 2025.
  • 207 funds tracked by Wall St. Rank held National Healthcare as of Q3 2025.

Based on Balyasny Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.